Adela López de Ceráin

Author

Also Known As

A Lopez de Cerain, A Lopez-de Cerain, A Lopez-de-Cerain, A LÓPez De Cerain, A López De Cerain, A López De Ceráin, A López de Cerain, A López de Ceráin, A. L. d. Cerain, A. LOPEZ DE CERAIN

228

Publications

6.6K

Citations

H-Index

109

Concepts

All Affiliations

Universidad de Navarra Universidad de la República de Uruguay Navarre Institute of Health Research Universidad Nacional de La Plata Universitat de Barcelona

About

Adela López de Ceráin is an author at Universidad de Navarra specializing in medicine, pharmacology, and toxicology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	59	2.8K
2	Natural Sciences	18	24	855
3	Health Sciences	10	10	545
4	Engineering	9	9	307
5	Public Health	2	2	126

Adela López de Ceráin

108

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Synthetic chalcones, flavanones, and flavones as antitumoral agents: Biological evaluation and structure–activity relationships Mauricio Cabrera, Macarena Simoens, Gabriela Falchi, Bioorganic & Medicinal Chemistry Medicinal ChemistryMedicineAntitumoral AgentsSynthetic ChalconesPhytochemical	2007	296
The role of oxidative stress in zearalenone-mediated toxicity in Hep G2 cells: Oxidative DNA damage, gluthatione depletion and stress proteins induction Wafa Hassen, Imen Ayed‐Boussema, Amaya Azqueta, Toxicology Reductive StressHep G2 CellsBiochemistryMedicineLipid Peroxidation	2007	170
Vanadium(V) complexes with salicylaldehyde semicarbazone derivatives bearing in vitro anti-tumor activity toward kidney tumor cells (TK-10): crystal structure of [VVO2(5-bromosalicylaldehyde semicarbazone)] Marisol Vieites, Beatriz S. Parajón‐Costa, Enrique J. Baran, Journal of Inorganic Biochemistry Inorganic ChemistryCrystal StructureCoordination ComplexKidney Tumor CellsVitro Anti-tumor Activity	2004	128
Hypoxia-Selective Agents Derived from Quinoxaline 1,4-Di-N-oxides Antonio Monge, Juan Antonio Palop, Adela López de Ceráin, Journal of Medicinal Chemistry	1995	123
Hypoxia-Selective Agents Derived from 2-Quinoxalinecarbonitrile 1,4-Di-N-oxides. 2 Antonio Monge, F. J. MARTINEZ‐CRESPO, Adela López de Ceráin, Journal of Medicinal Chemistry Organic ChemistryHypoxic CellsPharmacotherapyNew SeriesChemistry	1995	123
Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity Leire Arbillaga, Amaya Azqueta, Olga Ezpeleta, Mutagenesis Dna DamageLipid PeroxidationCell DeathPathologyMycotoxins	2006	111
Study on ochratoxin A in cereal-derived products from Spain C. Araguás, Elena González‐Peñas, Adela López de Ceráin Food Chemistry Food ChemistryBiosynthesisMycotoxin FormationOchratoxin AFood Toxicology	2004	110
DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours A. Marín, Adela López de Ceráin, Elizabeth Hamilton, British Journal of Cancer B5 ReductaseBiochemistryOncogenic AgentHuman LungMedicine	1997	110
Determination of ochratoxin A in wine using liquid-phase microextraction combined with liquid chromatography with fluorescence detection Elena González‐Peñas, C Leache, M Viscarret, Journal of Chromatography A Fluorescence DetectionGas ChromatographyBioanalysisLiquid-phase MicroextractionAnalytical Chemistry	2003	102
Immunotoxic effects of Ochratoxin A in wistar rats after oral administration Laura Álvarez, Ana Gloria Gil, Olga Ezpeleta, Food and Chemical Toxicology InflammationImmunotoxicologyMedicineImmunologyWistar Rats	2004	93

Page 1